ENTA – enanta pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Enanta Pharmaceuticals (ENTA) Moves to Buy: Rationale Behind the Upgrade [Yahoo! Finance]
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $21.00 price target on the stock.
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.
Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2024 [Yahoo! Finance]
Form SCHEDULE 13D/A ENANTA PHARMACEUTICALS Filed by: Luly Jay R.
Form 4 ENANTA PHARMACEUTICALS For: Feb 12 Filed by: Luu Brendan
Form 4 ENANTA PHARMACEUTICALS For: Feb 12 Filed by: Kieffer Tara Lynn
Form 4 ENANTA PHARMACEUTICALS For: Feb 12 Filed by: Rottinghaus Scott T.
Form 4 ENANTA PHARMACEUTICALS For: Feb 12 Filed by: Or Yat Sun
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.